These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7426385)

  • 41. Calcitonin-induced change in serum calcium levels and its relationship to osteoclast morphology and number of calcitonin receptors.
    Ikegame M; Ejiri S; Ozawa H
    Bone; 2004 Jul; 35(1):27-33. PubMed ID: 15207738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5(-/-) mice.
    Nijenhuis T; van der Eerden BC; Hoenderop JG; Weinans H; van Leeuwen JP; Bindels RJ
    J Bone Miner Res; 2008 Nov; 23(11):1815-24. PubMed ID: 18597625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of calcitonin gene-related peptide on bone resorption mediated by interleukin-1.
    Zhang WZ; Yu SF; Zheng LF
    Chin Med J (Engl); 1994 May; 107(5):351-4. PubMed ID: 7924575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence that protein kinase-A, calcium-calmodulin kinase and cytoskeletal proteins are involved in osteoclast retraction induced by calcitonin.
    Zheng MH; Wood DJ; Papadimitriou JM; Nicholson GC
    Exp Mol Pathol; 1992 Oct; 57(2):105-15. PubMed ID: 1426155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of bone resorption and increased incorporation of 3H-glucosamine into hyaluronate in bone organ cultures treated with dibutyryl cyclic AMP and colchicine.
    Severson AR
    Exp Cell Biol; 1983; 51(2):70-6. PubMed ID: 6301905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Action of calcitonin on osteoclasts in Paget's bone disease during long term treatment (author's transl)].
    Rebel A; Basle M; Minard MF; Malkani K
    Pathol Biol (Paris); 1977 Nov; 25(9):611-6. PubMed ID: 202910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Forskolin mimics the effects of calcitonin but not parathyroid hormone on bone resorption in vitro.
    Klein RF; Nissenson RA; Strewler GJ
    Bone Miner; 1988 Jul; 4(3):247-56. PubMed ID: 2847839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histologic study of the inhibition of bone resorption in organ cultures by myo-inositol-2-monophosphate.
    Gomes BC; Kaufman HW; Archard HO; Cangemi C; Guerra A
    J Oral Pathol; 1986 Jan; 15(1):54-8. PubMed ID: 2935605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of parathyroid hormone and calcitonin on carbonic anhydrase location in osteoclasts of cultured embryonic chick bone.
    Cao H; Gay CV
    Experientia; 1985 Nov; 41(11):1472-4. PubMed ID: 3933999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diphosphonates inhibit bone resorption by macrophages in vitro.
    Chambers TJ
    J Pathol; 1980 Nov; 132(3):255-62. PubMed ID: 7431161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of diphosphonate-blocked bone mineralization. Evidence that calcitonin promotes mineralization.
    Boris A; Hurley JF; Trmal T; Mallon JP; Matuszewski DS
    Acta Endocrinol (Copenh); 1979 Jun; 91(2):351-61. PubMed ID: 463451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
    Lerner UH
    J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human synthetic calcitonin gene-related peptide inhibits bone resorption in vitro.
    D'Souza SM; MacIntyre I; Girgis SI; Mundy GR
    Endocrinology; 1986 Jul; 119(1):58-61. PubMed ID: 3487444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet-activating factor induces pseudopod formation in calcitonin-treated rabbit osteoclasts.
    Gravel MR; Zheng ZG; Sims SM; Dixon SJ
    J Bone Miner Res; 1994 Nov; 9(11):1769-76. PubMed ID: 7863828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acid extrusion is induced by osteoclast attachment to bone. Inhibition by alendronate and calcitonin.
    Zimolo Z; Wesolowski G; Rodan GA
    J Clin Invest; 1995 Nov; 96(5):2277-83. PubMed ID: 7593614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclosporin-A in vitro decreases bone resorption, osteoclast formation, and the fusion of cells of the monocyte-macrophage lineage.
    Orcel P; Denne MA; de Vernejoul MC
    Endocrinology; 1991 Mar; 128(3):1638-46. PubMed ID: 1999178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of continuous calcitonin treatment on osteoclasts derived from cocultures of mouse marrow stromal and spleen cells.
    Liu BY; Wang JT; Leu JS; Chiang CP; Hsieh CC; Kwan HW
    J Formos Med Assoc; 2000 Feb; 99(2):140-50. PubMed ID: 10770029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diphosphonates: therapeutic agents to inhibit bone resorption.
    Mariani NA; Rowe DJ
    Iowa Dent J; 1988 Jan; 74(1):38-9. PubMed ID: 3163328
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of dichloromethylene diphosphonate on morphology, enzyme activity, and ash content of bones of thyroparathyroidectomized rats.
    Weisbrode SE; Capen CC; Pendley CB
    Calcif Tissue Res; 1978 May; 25(2):119-26. PubMed ID: 149584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of dichloromethylene diphosphonate (Cl2MDP) and calcitonin on bone resorption, lactate production and phosphatase and pyrophosphatase content of mouse calvaria treated with parathyroid hormone in vitro.
    Morgan DB; Monod A; Russel RG; Fleisch H
    Calcif Tissue Res; 1973 Dec; 13(4):287-94. PubMed ID: 4362818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.